RSL-3 can block the mTOR activation to promote GPX4 protein degradation in pancreatic cancer cells (Liu et al., 2021), which facilitates the autophagy-dependent ferroptosis induced by RSL-3 (Chen et al., 2021). Here, GPX4 is linked to pancreatic neoplasm.